Back to Archived Journals » Comparative Effectiveness Research

Comparative Effectiveness Research ceased publishing in September 2018. All articles that have been published in Comparative Effectiveness Research will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Comparative Effectiveness Research

ISSN: 1179-8483


       

Journal Articles:

- 32 records -

Local triamcinolone acetonide injection for treatment of nasal tip cysts

Li Z, Wang M, Zhang L, Zhang N, Xiang N, Fu ZQ

Comparative Effectiveness Research 2018, 8:19-21

Published Date: 27 April 2018

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

Li J, Ren HY, Zhang J, Dong P, Wang Y, Stevens AL, Han Y, Huang M

Comparative Effectiveness Research 2018, 8:1-2

Published Date: 24 January 2018

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Li J, Ren HY, Zhang J, Dong P, Wang Y, Stevens AL, Han Y, Huang M

Comparative Effectiveness Research 2017, 7:1-9

Published Date: 23 January 2017

Evidence-based research: understanding the best estimate

Bauer JG, Spackman SS, Fritz R, Bains AK, Jetton-Rangel J

Comparative Effectiveness Research 2016, 6:23-31

Published Date: 7 September 2016

Matching-adjusted indirect treatment comparison in patients with radioiodine-refractory differentiated thyroid cancer

Tremblay G, Holbrook T, Milligan G, Pelletier CL, Rietschel P

Comparative Effectiveness Research 2016, 6:13-21

Published Date: 20 April 2016

Unannounced or announced periodic hospital surveys: a study protocol for a nationwide cluster-randomized controlled trial

Simonsen KB, Olesen AV, Jensen MB, Rasmussen GS, Ehlers LH

Comparative Effectiveness Research 2015, 5:57-63

Published Date: 1 September 2015

Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

Hao Y, Meyer N, Landsman-Blumberg P, Johnson W, Willemann Rogerio J

Comparative Effectiveness Research 2015, 5:35-47

Published Date: 28 April 2015

Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

Meyer N, Hao Y, Landsman-Blumberg P, Johnson W, Juneau P, Willemann Rogerio J

Comparative Effectiveness Research 2015, 5:21-34

Published Date: 28 April 2015

Defining the benefits and challenges of stakeholder engagement in systematic reviews

Cottrell EK, Whitlock EP, Kato E, Uhl S, Belinson S, Chang C, Hoomans T, Meltzer DO, Noorani H, Robinson KA, Motu’apuaka M, Anderson J, Paynter RA, Guise JM

Comparative Effectiveness Research 2015, 5:13-19

Published Date: 16 April 2015

When patient-centeredness and evidence-based medicine collide

Braithwaite RS

Comparative Effectiveness Research 2014, 4:29-32

Published Date: 5 July 2014

Current issues in comparative effectiveness research for hepatitis C

Yoo M, Cheng Y, Rhien TJ, Biskupiak J

Comparative Effectiveness Research 2014, 4:13-27

Published Date: 26 June 2014

Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience

Friedly JL, Bauer Z, Comstock BA, DiMango E, Ferrara A, Huang SS, Israel E, Jarvik JG, Nierenberg AA, Ong MK, Penson DF, Smith-Bindman R, Stillman AE, Vollmer WM, Warren SM, Zhan C, Hsia DC, Trontell A

Comparative Effectiveness Research 2014, 4:1-12

Published Date: 3 May 2014

Using customer-focused research and design to build a self-service online store: a case study

Ahmadi MB, Trefzger W, Morey R, Quintas I

Comparative Effectiveness Research 2013, 3:21-32

Published Date: 5 February 2013

A tool for assessing the feasibility of comparative effectiveness research

Walker AM, Patrick AR, Lauer MS, Hornbrook MC, Marin MG, Platt R, Roger VL, Stang P, Schneeweiss S

Comparative Effectiveness Research 2013, 3:11-20

Published Date: 30 January 2013

Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states?

Crowley MJ, Powers BJ, Myers ER, McCrory DC, McBroom AJ, Sanders GD

Comparative Effectiveness Research 2013, 3:1-9

Published Date: 10 January 2013

A more rapid approach to systematically assessing published associations of genetic polymorphisms and disease risk: type 2 diabetes as a test case

Cho AH, Jiang X, Mann DM, Kawamoto K, Robinson TJ, Wang N, McCarthy JJ, Woodward M, Ginsburg GS

Comparative Effectiveness Research 2012, 2:1-20

Published Date: 26 January 2012

Telemedicine vs in-person cancer genetic counseling: measuring satisfaction and conducting economic analysis

Datta SK, Buchanan AH, Hollowell GP, Beresford HF, Marcom PK, Adams MB

Comparative Effectiveness Research 2011, 1:43-50

Published Date: 19 May 2011

Challenges and opportunities in comparative effectiveness research

Voils CI, Maciejewski ML

Comparative Effectiveness Research 2011, 1:39-41

Published Date: 19 April 2011